Advertisement

Reactions Weekly

, Volume 1695, Issue 1, pp 99–99 | Cite as

Ceritinib

Development of resistance in colorectal adenocarcinoma: case report
Case report
  • 14 Downloads

Reference

  1. Yakirevich E, et al. Oncogenic ALK Fusion in Rare and Aggressive Subtype of Colorectal Adenocarcinoma as a Potential Therapeutic Target. Clinical cancer research: an official journal of the American Association for Cancer Research 22: 3831-3840, No. 15, Aug 2016. Available from: URL: http://doi.org/10.1158/1078-0432.CCR-15-3000 - USACrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations